Pharmacosmos Overview

  • Founded
  • 1965
Founded
  • Status
  • Private
  • Employees
  • 172
Employees
  • Latest Deal Type
  • Corporate
  • Financing Rounds
  • 1

Pharmacosmos General Information

Description

Developer of medicines for the treatment of iron deficiency anaemia in humans and animals. The company is engaged in research and development for the synthesis of iron-carbohydrate complexes to bring better treatments for patients suffering from iron deficiency.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Primary Office
  • Roervangsvej 30
  • 4300 Holbaek
  • Denmark
+45 59 00 00 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Pharmacosmos Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Pharmacosmos‘s full profile, request access.

Request a free trial

Pharmacosmos Patents

Pharmacosmos Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20210290587-A1 Treating iron deficiency with ferric carboxymaltose Pending 29-Oct-2018 0000000000
CA-3117071-A1 Treating iron deficiency with ferric carboxymaltose Pending 29-Oct-2018 000000000
AU-2019370677-A1 Treating iron deficiency with ferric carboxymaltose Pending 29-Oct-2018 000000000
US-20200281887-A1 Treating iron deficiency with ferric carboxymaltose Granted 29-Oct-2018 0000000000
US-11020369-B2 Treating iron deficiency with ferric carboxymaltose Active 29-Oct-2018 G01N33/90 0

Pharmacosmos Executive Team (4)

Name Title Board Seat Contact Info
Lars Christensen MD President & Chief Executive Officer
Robert Guglielmetti Chief Financial Officer & Executive Vice President
Hans Andreasen Chief Scientific Officer & Vice President
Lars Thomsen Chief Medical Officer & Vice President
To view Pharmacosmos’s complete executive team members history, request access »

Pharmacosmos Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial